Suzanne E Wardell

12PUBLICATIONS
82CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsEnvironmental epidemiologyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 12, 2025
The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models.

Jianhui Ma, Sayee Hegde, Masha Sergeeva

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|Nov 19, 2024
PKN2 Is a Dependency of the Mesenchymal-like Cancer Cell State.

Shane T Killarney, Gabriel Mesa, Rachel Washart

|Sep 27, 2024
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth.

Sandeep Artham, Patrick K Juras, Aditi Goyal

|Sep 03, 2024
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells.

Rachid Safi, Suzanne E Wardell, Paige Watkinson

|Apr 11, 2023
ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1.

Benjamin Mayro, Jacob P Hoj, Christian G Cerda-Smith

Pageof 2

Frequent Collaborators

9 joint publications

Donald P McDonnell

5 joint publications

Kris C Wood

2 joint publications

Benjamin Mayro

2 joint publications

Qingshan Wei